Established in 2005, CATAG is the peak national advisory body, a collaborative of all Australian state and territory therapeutic or medicines advisory groups.
CATAG is a collaboration of 9 state and territory Therapeutic or Medicines Advisory Groups:
- Canberra Health Services
- NSW Clinical Excellence Commission (CEC)
- NSW Therapeutic Advisory Group (NSW TAG)
- Northern Territory Department of Health
- Queensland Health Medicines Advisory Committee (QHMAC)
- South Australian Medicines Advisory Committee (SAMAC)
- Tasmanian Medicines Access and Advisory Committee (TMAAC)
- Victorian Therapeutics Advisory Group (VicTAG)
- Western Australian Therapeutics Advisory Group (WATAG)
Supports Quality Use of Medicine (QUM) in the acute care sector
CATAG aims to improve medicines management and use within the framework of the National Medicines Policy as it applies to clinical practice in Australian hospitals, at the interfaces of care, within the public sector and wider community. It promotes the equitable, safe, cost-effective and quality use of medicines, with the objective of realising the best possible health outcomes for all Australians. This also contributes to improved value and sustainability in the health system.
Improves medicines management and use
CATAG aims to improve medicines management and use within the framework of the National Medicines Policy as it applies to clinical practice in Australian hospitals, at transitions of care, within the public sector and wider community. It promotes the equitable, safe, cost-effective and quality use of medicines, with the objective of realising the best possible health outcomes for all Australians. This also contributes to improved value and sustainability in the health system.
Supports Drugs and Therapeutic Committees (DTC)
CATAG supports Drugs and Therapeutics Committees (DTC) to be well functioning which leads to a strong QUM framework within the individual health service. The framework then influences GP prescribing, through specialist prescribing practices filtering into the community when patients are discharged from the acute care setting.
Independent and cognizant of QUM issues and cost pressures
CATAG is independent and cognizant of QUM issues and the cost pressures faced by governments, policy decision makers, individual healthcare organisations and clinicians. CATAG is able to react immediately to changes in practice/evidence, with a particular focus on acute care.
CATAG is an independent entity, with current funding provided by NPS MedicineWise and hosted by NSW Therapeutic Advisory Group (TAG). CATAG is governed by the CATAG Executive, which consists of the current Chair, the immediate past Chair and a representative from the hosting organisation (NSW TAG). The Executive is responsible for ensuring CATAG meets its functions and responsibilities.
Terms of reference
Associate Professor Bhavini Patel
Bhavini Patel is the Executive Director of Medicines Management and Research for NT Health and has been the NT Executive COVID-19 Vaccine Lead since late 2020. Bhavini is an Advanced Practice Pharmacist with clinical expertise in renal and cardiovascular medicine and a special interest in how clinical pharmacists can improve the safety of and optimise outcomes associated with the quality use of medicines. Bhavini’s research interests include how to redesign systems of care to improve equity and access and how information technology can assist in this process.
Bhavini is an inaugural member of Council of Australian Therapeutic Advisory Groups and has held a number of leadership positions during her career. She has lived and worked in the NT for the last 20 years and finds the relaxed outdoor lifestyle a good balance to the demands of her work. Bhavini was the recipient of the Society of Hospital Pharmacists of Australia in 2011 Medal of Merit for establishing and growing hospital pharmacy practice in regional and remote Australia and was awarded Professional Excellence status in the NT for her Clinical Leadership practice in 2020.
CATAG’s staff is dedicated to working towards facilitating quality use of medicines in Australian public hospitals.
Enthusiastic about educating health practitioners on best practice medication use. Extensive experience in clinical practice and research, including education and research, clinical pharmacy, quality use of medicine.
CATAG is funded by NPS MedicineWise together with in kind resources provided by the CATAG member organisations.
CATAG may also receive additional funding to undertake specific projects or participate in consortium led applications for grants.